Phoenixin-14 (PNX) is a neuropeptide that has been shown to prevent oxidative damage and stimulates insulin secretion. We investigated the effects of PNX on pancreatic injury induced by streptozotocin (STZ), and nicotinamide (NAD). Male Sprague-Dawley rats, in control (C) and diabetic (STZ) groups, were treated with either saline, or PNX (0.45 nmol/kg, or 45 nmol/kg) daily for 3 days 1 week after STZ injection. Fasting blood glucose (FBG) and gastric emptying rate (GER) were measured. Tissue and blood samples were collected. PNX treatments prevented pancreatic damage and β cell loss. Increased luminol and lucigenin levels in the pancreas, ileum and liver tissues of STZ groups were alleviated by PNX treatment in pancreatic and ileal tissues. PNX0.45 decreased FBG without any change in insulin blood level and pancreatic mRNA. GER increased in all diabetic rats while PNX0.45 delayed GER only in the C group. PNX diminishes pancreatic damage and lowers FBG by reducing oxidative load.
Accurate differentiation between tumor recurrence and other neurological complications remains challenging in pediatric neuro-oncology. Medulloblastoma, the most common malignant pediatric brain tumor, may present with new intracranial lesions after surgery and chemoradiotherapy that mimic recurrence but actually arise from infection or autoimmune limbic encephalitis. We report a 5-year-5-month-old girl with cerebellar medulloblastoma (WHO CNS5 grade 4, non-WNT/non-SHH, Group 3/4) who developed fever, drowsiness, and vomiting 7 months post-therapy. Magnetic Resonance Imaging (MRI) revealed unilateral right anteromedial temporal and hippocampal fluid-attenuated inversion recovery hyperintensity with insular extension, restricted diffusion, and a small frontal microhemorrhage without contrast enhancement. Cerebrospinal fluid analysis confirmed herpes simplex virus-1 infection. Correlating MRI findings with cerebrospinal fluid results and tumor molecular profile allowed early antiviral treatment, distinguishing infection from recurrence or limbic encephalitis and avoiding unnecessary oncologic interventions. This case emphasizes the importance of multimodal imaging and laboratory correlation in the post-treatment evaluation of pediatric medulloblastoma.
Osmotic demyelination syndrome (ODS) is a rare acute demyelinating process that typically develops within days following osmotic stress. Although most commonly associated with the rapid correction of hyponatremia, chronic hypernatremia has also been reported as an etiological factor. Herein, we present a 16-year-old female patient who developed ODS secondary to electrolyte imbalance following treatment for acute myeloid leukemia (AML). Brain Magnetic Resonance Imaging (MRI) plays a pivotal role in enabling accurate diagnosis. Due to the involvement of both upper motor neurons (UMN) and lower motor neurons (LMN), this case represents a rare pediatric presentation with coexisting UMN signs and electrophysiologic LMN involvement.